Gene symbol   |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
1700055N 04Rik | |
AK081788 |
16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130077J09 product:weakly similar to ALDEHYDE DEHYDROGENASE 7 (EC 1.2.1.5) [Homo sapiens], full insert sequence [AK081788] |
KLA | .96 |
.98 |
.95 |
.97 |
.97 |
.96 |
1.06 |
| ATP | 1.01 |
1.00 |
.97 |
1.10 |
.95 |
.99 |
1.02 |
| KLA/ATP | .99 |
1.00 |
.97 |
1.00 |
1.00 |
.96 |
.97 |
|
Adh1 | |
AK082149 |
0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230014D21 product:unclassifiable, full insert sequence [AK082149] |
KLA | .94 |
.96 |
.97 |
.95 |
1.01 |
.95 |
.96 |
| ATP | .99 |
1.05 |
.93 |
.91 |
1.02 |
1.04 |
1.00 |
| KLA/ATP | .87 |
.88 |
.94 |
.92 |
.86 |
1.04 |
.93 |
|
Adh1 | |
NM_007409 |
alcohol dehydrogenase 1 (class I) (Adh1), mRNA [NM_007409] |
KLA | 1.02 |
.98 |
.96 |
1.04 |
1.01 |
1.04 |
1.08 |
| ATP | .96 |
1.03 |
1.00 |
1.03 |
1.05 |
1.01 |
1.04 |
| KLA/ATP | 1.02 |
1.03 |
1.04 |
1.01 |
1.04 |
1.09 |
1.04 |
|
Adh4 | |
NM_011996 |
alcohol dehydrogenase 4 (class II), pi polypeptide (Adh4), mRNA [NM_011996] |
KLA | .95 |
.94 |
.93 |
1.07 |
1.04 |
.96 |
.99 |
| ATP | .95 |
.95 |
.95 |
.99 |
1.02 |
.93 |
.97 |
| KLA/ATP | 1.03 |
1.02 |
.92 |
.97 |
1.02 |
1.01 |
.99 |
|
Adh5 | |
NM_007410 |
alcohol dehydrogenase 5 (class III), chi polypeptide (Adh5), mRNA [NM_007410] |
KLA | .93 |
.76 |
.71 |
.83 |
.61 |
.63 |
.76 |
| ATP | 1.02 |
.98 |
1.19 |
1.06 |
1.08 |
.85 |
.86 |
| KLA/ATP | .77 |
.76 |
1.06 |
.86 |
.87 |
.84 |
.62 |
|
Adh7 | |
NM_009626 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide (Adh7), mRNA [NM_009626] |
KLA | 1.07 |
1.01 |
1.02 |
.98 |
1.03 |
.99 |
1.01 |
| ATP | 1.03 |
1.09 |
1.02 |
1.08 |
1.03 |
1.09 |
1.01 |
| KLA/ATP | 1.10 |
1.03 |
1.06 |
1.02 |
1.05 |
1.06 |
1.13 |
|
Aldh1a3 | |
AK086764 |
15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930050B08 product:aldehyde dehydrogenase family 1, subfamily A3, full insert sequence. [AK086764] |
KLA | .97 |
1.05 |
1.05 |
1.01 |
1.00 |
.98 |
.97 |
| ATP | 1.00 |
1.03 |
.99 |
.92 |
1.01 |
1.09 |
1.02 |
| KLA/ATP | 1.01 |
.99 |
1.06 |
1.00 |
.97 |
.98 |
1.00 |
|
Aldh1a3 | |
NM_053080 |
aldehyde dehydrogenase family 1, subfamily A3 (Aldh1a3), mRNA [NM_053080] |
KLA | 1.03 |
.96 |
1.03 |
1.03 |
.96 |
.98 |
1.01 |
| ATP | .98 |
1.04 |
1.01 |
1.06 |
.98 |
1.01 |
1.08 |
| KLA/ATP | 1.02 |
1.00 |
1.02 |
.94 |
1.03 |
.99 |
.99 |
|
Aldh3a1 | |
NM_007436 |
aldehyde dehydrogenase family 3, subfamily A1 (Aldh3a1), transcript variant 1, mRNA [NM_007436] |
KLA | .98 |
.98 |
1.03 |
1.01 |
1.03 |
1.04 |
.97 |
| ATP | .98 |
1.01 |
1.06 |
.95 |
1.00 |
.96 |
1.02 |
| KLA/ATP | 1.07 |
1.08 |
.99 |
.98 |
1.03 |
.93 |
.98 |
|
Aldh3b1 | |
NM_026316 |
aldehyde dehydrogenase 3 family, member B1 (Aldh3b1), mRNA [NM_026316] |
KLA | .82 |
.77 |
.69 |
.77 |
.72 |
.97 |
1.31 |
| ATP | .88 |
.85 |
1.13 |
.89 |
.71 |
.56 |
1.25 |
| KLA/ATP | .66 |
.72 |
.84 |
.66 |
.66 |
.52 |
1.17 |
|
Aldh3b2 | |
XM_129134 |
gb|PREDICTED: Mus musculus aldehyde dehydrogenase 3 family, member B2 (Aldh3b2), mRNA [XM_129134] |
KLA | .91 |
.93 |
.85 |
.88 |
1.01 |
.99 |
1.37 |
| ATP | 1.12 |
1.11 |
.99 |
1.19 |
.87 |
.61 |
1.31 |
| KLA/ATP | .86 |
1.02 |
.90 |
1.01 |
.72 |
.54 |
1.21 |
|
Arnt | |
AK037762 |
16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130047M16 product:aryl hydrocarbon receptor nuclear translocator, full insert sequence. [AK037762] |
KLA | 1.01 |
.87 |
.97 |
.92 |
1.13 |
.91 |
1.00 |
| ATP | 1.16 |
1.22 |
1.22 |
.84 |
1.57 |
1.19 |
1.05 |
| KLA/ATP | 1.06 |
1.06 |
1.08 |
.95 |
1.40 |
1.18 |
1.06 |
|
Arnt | |
NM_001037737 |
aryl hydrocarbon receptor nuclear translocator (Arnt), transcript variant 1, mRNA [NM_001037737] |
KLA | 1.23 |
1.27 |
1.32 |
1.23 |
1.34 |
1.33 |
1.30 |
| ATP | 1.02 |
1.09 |
.96 |
.90 |
.99 |
1.33 |
1.38 |
| KLA/ATP | 1.30 |
1.28 |
1.05 |
1.12 |
1.07 |
1.64 |
1.89 |
|
Arnt | |
U14333 |
aromatic hydrocarbon receptor nuclear translocator Arnt (ARNT) mRNA, complete cds. [U14333] |
KLA | 1.78 |
1.78 |
1.78 |
1.85 |
1.64 |
1.71 |
1.40 |
| ATP | .96 |
1.05 |
1.37 |
1.24 |
1.19 |
2.13 |
2.37 |
| KLA/ATP | 1.72 |
1.87 |
1.87 |
1.83 |
1.53 |
2.53 |
3.65 |
|
Cbr1 | |
U31966 |
carbonyl reductase (Cbr1) mRNA, complete cds. [U31966] |
KLA | .79 |
.82 |
.80 |
.76 |
.69 |
.91 |
.89 |
| ATP | .95 |
.90 |
1.24 |
1.29 |
1.39 |
1.58 |
2.18 |
| KLA/ATP | .82 |
.79 |
1.22 |
1.01 |
1.41 |
1.76 |
1.89 |
|
Ccbl1 | |
NM_172404 |
cysteine conjugate-beta lyase 1 (Ccbl1), mRNA [NM_172404] |
KLA | .68 |
.64 |
.61 |
.59 |
.58 |
.75 |
.89 |
| ATP | 1.02 |
.96 |
.89 |
.80 |
.63 |
.48 |
.97 |
| KLA/ATP | .71 |
.68 |
.61 |
.64 |
.53 |
.50 |
.60 |
|
Ccbl2 | |
NM_173763 |
cysteine conjugate-beta lyase 2 (Ccbl2), mRNA [NM_173763] |
KLA | 2.01 |
2.14 |
2.03 |
1.98 |
1.40 |
.85 |
.65 |
| ATP | .96 |
.91 |
1.14 |
.95 |
.81 |
1.04 |
.68 |
| KLA/ATP | 2.05 |
2.10 |
2.27 |
1.79 |
1.55 |
1.00 |
.57 |
|
Chrna7 | |
NM_007390 |
cholinergic receptor, nicotinic, alpha polypeptide 7 (Chrna7), mRNA [NM_007390] |
KLA | 1.01 |
.99 |
1.04 |
.96 |
.99 |
.99 |
1.01 |
| ATP | .99 |
.97 |
1.00 |
1.00 |
.99 |
1.04 |
1.00 |
| KLA/ATP | .98 |
1.02 |
1.04 |
.99 |
.95 |
.96 |
1.07 |
|
Cyp1a1 | |
NM_009992 |
cytochrome P450, family 1, subfamily a, polypeptide 1 (Cyp1a1), mRNA [NM_009992] |
KLA | 1.07 |
.99 |
1.02 |
1.01 |
1.00 |
1.00 |
1.11 |
| ATP | .99 |
1.02 |
1.01 |
.95 |
.96 |
.94 |
1.09 |
| KLA/ATP | 1.01 |
1.03 |
.98 |
.96 |
.96 |
.95 |
1.51 |
|
Cyp1a2 | |
NM_009993 |
cytochrome P450, family 1, subfamily a, polypeptide 2 (Cyp1a2), mRNA [NM_009993] |
KLA | 1.01 |
.99 |
.98 |
1.02 |
.97 |
.97 |
1.00 |
| ATP | 1.01 |
.98 |
1.03 |
1.01 |
1.04 |
1.02 |
1.04 |
| KLA/ATP | .99 |
1.00 |
1.05 |
1.03 |
.98 |
.97 |
.99 |
|
Cyp1b1 | |
AK016699 |
adult male testis cDNA, RIKEN full-length enriched library, clone:4933406K16 product:cytochrome P450, 1b1, benz[a]anthracene inducible, full insert sequence. [AK016699] |
KLA | 1.00 |
1.03 |
1.00 |
1.02 |
1.02 |
.97 |
1.03 |
| ATP | 1.00 |
1.04 |
1.03 |
1.13 |
1.04 |
1.05 |
1.02 |
| KLA/ATP | 1.06 |
1.03 |
.96 |
1.05 |
1.07 |
1.12 |
1.09 |
|
Cyp1b1 | |
NM_009994 |
cytochrome P450, family 1, subfamily b, polypeptide 1 (Cyp1b1), mRNA [NM_009994] |
KLA | 1.02 |
.99 |
1.04 |
1.05 |
.98 |
1.00 |
1.07 |
| ATP | 1.05 |
1.01 |
1.05 |
1.19 |
1.09 |
2.31 |
5.32 |
| KLA/ATP | .99 |
1.02 |
1.05 |
1.06 |
1.14 |
1.39 |
3.15 |
|
Cyp2a12 | |
NM_133657 |
cytochrome P450, family 2, subfamily a, polypeptide 12 (Cyp2a12), mRNA [NM_133657] |
KLA | 1.03 |
1.08 |
1.00 |
.98 |
1.00 |
1.03 |
1.03 |
| ATP | 1.01 |
.98 |
1.03 |
1.08 |
1.02 |
.99 |
1.01 |
| KLA/ATP | .97 |
1.01 |
.97 |
1.06 |
1.03 |
1.03 |
.99 |
|
Cyp2a4 | |
NM_009997 |
cytochrome P450, family 2, subfamily a, polypeptide 4 (Cyp2a4), mRNA [NM_009997] |
KLA | 1.02 |
.99 |
1.00 |
1.00 |
.98 |
1.04 |
1.01 |
| ATP | 1.01 |
1.00 |
1.01 |
1.03 |
.99 |
1.01 |
.99 |
| KLA/ATP | 1.03 |
1.03 |
1.01 |
1.04 |
.98 |
1.03 |
1.01 |
|
Cyp2a5 | |
NM_007812 |
cytochrome P450, family 2, subfamily a, polypeptide 5 (Cyp2a5), mRNA [NM_007812] |
KLA | 1.04 |
.95 |
.95 |
1.02 |
1.01 |
.94 |
1.06 |
| ATP | 1.03 |
.95 |
1.05 |
1.08 |
.99 |
.97 |
1.03 |
| KLA/ATP | 1.01 |
1.06 |
.92 |
1.08 |
1.05 |
1.01 |
1.01 |
|
Cyp2b10 | |
NM_009999 |
cytochrome P450, family 2, subfamily b, polypeptide 10 (Cyp2b10), transcript variant 2, mRNA [NM_009999] |
KLA | .98 |
1.03 |
.97 |
1.02 |
1.02 |
.97 |
1.03 |
| ATP | 1.03 |
.99 |
1.02 |
1.02 |
.98 |
1.02 |
.99 |
| KLA/ATP | 1.04 |
1.00 |
1.02 |
.93 |
.97 |
.93 |
.91 |
|
Cyp2b13 | |
NM_007813 |
cytochrome P450, family 2, subfamily b, polypeptide 13 (Cyp2b13), mRNA [NM_007813] |
KLA | .99 |
1.02 |
1.00 |
1.06 |
1.05 |
1.03 |
.99 |
| ATP | .96 |
.96 |
.96 |
.98 |
.99 |
.95 |
.98 |
| KLA/ATP | 1.00 |
1.03 |
1.04 |
1.02 |
1.01 |
1.06 |
.99 |
|
Cyp2b19 | |
AK029227 |
0 day neonate head cDNA, RIKEN full-length enriched library, clone:4831430P04 product:cytochrome P450, 2b19, full insert sequence. [AK029227] |
KLA | .96 |
.98 |
1.02 |
1.09 |
1.06 |
1.00 |
1.08 |
| ATP | 1.02 |
1.06 |
.91 |
1.05 |
1.00 |
.97 |
.95 |
| KLA/ATP | .99 |
.93 |
.96 |
1.03 |
1.00 |
1.04 |
1.00 |
|
Cyp2b19 | |
NM_007814 |
cytochrome P450, family 2, subfamily b, polypeptide 19 (Cyp2b19), mRNA [NM_007814] |
KLA | 1.14 |
1.20 |
1.18 |
1.17 |
1.17 |
1.21 |
1.14 |
| ATP | .96 |
1.01 |
1.11 |
1.08 |
.99 |
1.08 |
1.10 |
| KLA/ATP | 1.09 |
1.05 |
1.17 |
1.16 |
1.16 |
1.10 |
1.07 |
|
Cyp2b23 | |
NM_001081148 |
cytochrome P450, family 2, subfamily b, polypeptide 23 (Cyp2b23), mRNA [NM_001081148] |
KLA | 1.09 |
.96 |
1.01 |
.95 |
.97 |
1.01 |
.92 |
| ATP | .97 |
1.00 |
.92 |
.92 |
.98 |
.97 |
.94 |
| KLA/ATP | 1.01 |
1.02 |
1.03 |
.94 |
.94 |
.93 |
.97 |
|
Cyp2b9 | |
NM_010000 |
cytochrome P450, family 2, subfamily b, polypeptide 9 (Cyp2b9), mRNA [NM_010000] |
KLA | .99 |
1.00 |
1.02 |
1.01 |
1.03 |
.98 |
1.03 |
| ATP | 1.01 |
.98 |
.97 |
.98 |
1.01 |
.96 |
.98 |
| KLA/ATP | 1.00 |
1.04 |
.94 |
1.04 |
1.02 |
1.03 |
.99 |
|
Cyp2c29 | |
NM_007815 |
cytochrome P450, family 2, subfamily c, polypeptide 29 (Cyp2c29), mRNA [NM_007815] |
KLA | 1.01 |
.95 |
1.06 |
1.12 |
1.01 |
1.02 |
1.12 |
| ATP | 1.03 |
1.02 |
1.01 |
1.06 |
.98 |
.98 |
.96 |
| KLA/ATP | 1.09 |
1.14 |
1.02 |
.98 |
.99 |
.98 |
.98 |
|
Cyp2c37 | |
NM_010001 |
cytochrome P450, family 2. subfamily c, polypeptide 37 (Cyp2c37), mRNA [NM_010001] |
KLA | 1.27 |
1.43 |
1.64 |
1.52 |
1.65 |
1.43 |
1.45 |
| ATP | .99 |
.96 |
1.03 |
1.13 |
1.10 |
1.03 |
1.27 |
| KLA/ATP | 1.37 |
1.49 |
1.22 |
1.46 |
1.16 |
1.12 |
1.24 |
|
Cyp2c38 | |
NM_010002 |
cytochrome P450, family 2, subfamily c, polypeptide 38 (Cyp2c38), mRNA [NM_010002] |
KLA | 1.01 |
1.06 |
.98 |
.96 |
1.07 |
.98 |
.97 |
| ATP | 1.01 |
1.09 |
1.04 |
.98 |
1.00 |
1.03 |
.98 |
| KLA/ATP | 1.03 |
.98 |
1.03 |
1.04 |
1.00 |
1.00 |
1.01 |
|
Cyp2c39 | |
NM_010003 |
cytochrome P450, family 2, subfamily c, polypeptide 39 (Cyp2c39), mRNA [NM_010003] |
KLA | 1.04 |
1.01 |
.97 |
1.00 |
.99 |
1.01 |
.98 |
| ATP | 1.04 |
1.07 |
.95 |
1.00 |
.96 |
1.03 |
1.01 |
| KLA/ATP | 1.03 |
1.01 |
1.02 |
1.01 |
1.05 |
1.05 |
.99 |
|
Cyp2c40 | |
NM_010004 |
cytochrome P450, family 2, subfamily c, polypeptide 40 (Cyp2c40), mRNA [NM_010004] |
KLA | .96 |
1.06 |
1.05 |
1.03 |
.99 |
1.01 |
1.02 |
| ATP | .96 |
1.01 |
1.02 |
.97 |
1.01 |
1.02 |
.99 |
| KLA/ATP | 1.06 |
1.03 |
1.04 |
.98 |
1.05 |
1.01 |
.97 |
|
Cyp2c44 | |
NM_001001446 |
cytochrome P450, family 2, subfamily c, polypeptide 44 (Cyp2c44), mRNA [NM_001001446] |
KLA | .98 |
1.04 |
.93 |
1.05 |
1.01 |
.93 |
.94 |
| ATP | 1.02 |
1.01 |
1.01 |
1.04 |
1.02 |
1.02 |
1.00 |
| KLA/ATP | .93 |
.95 |
1.00 |
1.05 |
1.07 |
1.01 |
1.01 |
|
Cyp2c54 | |
NM_206537 |
cytochrome P450, family 2, subfamily c, polypeptide 54 (Cyp2c54), mRNA [NM_206537] |
KLA | .98 |
.99 |
1.04 |
.97 |
1.06 |
1.03 |
1.04 |
| ATP | .99 |
.98 |
1.10 |
1.03 |
1.03 |
.98 |
1.03 |
| KLA/ATP | 1.02 |
1.04 |
.89 |
.98 |
.99 |
.93 |
.99 |
|
Cyp2c55 | |
NM_028089 |
cytochrome P450, family 2, subfamily c, polypeptide 55 (Cyp2c55), mRNA [NM_028089] |
KLA | .97 |
1.02 |
1.01 |
.99 |
.99 |
1.00 |
.94 |
| ATP | 1.04 |
.98 |
1.09 |
.97 |
1.05 |
.99 |
1.06 |
| KLA/ATP | 1.04 |
1.01 |
1.15 |
1.03 |
1.05 |
1.05 |
1.09 |
|
Cyp2c65 | |
AK008688 |
adult male stomach cDNA, RIKEN full-length enriched library, clone:2210009K14 product:similar to CYTOCHROME P450 2C18 (EC 1.14.14.1) (CYPIIC18) (P450-6B [AK008688] |
KLA | .95 |
.97 |
1.02 |
1.00 |
.97 |
1.10 |
1.04 |
| ATP | .98 |
1.05 |
1.00 |
1.10 |
.98 |
.99 |
1.03 |
| KLA/ATP | .96 |
.97 |
.99 |
1.01 |
1.03 |
1.04 |
1.03 |
|
Cyp2c66 | |
NM_001011707 |
cytochrome P450, family 2, subfamily c, polypeptide 66 (Cyp2c66), mRNA [NM_001011707] |
KLA | 1.03 |
1.04 |
.99 |
1.00 |
1.06 |
1.11 |
1.01 |
| ATP | .97 |
1.01 |
1.03 |
1.00 |
.98 |
1.03 |
1.04 |
| KLA/ATP | 1.08 |
.97 |
1.15 |
1.02 |
1.04 |
1.06 |
1.08 |
|
Cyp2c70 | |
NM_145499 |
cytochrome P450, family 2, subfamily c, polypeptide 70 (Cyp2c70), mRNA [NM_145499] |
KLA | 1.05 |
.94 |
.95 |
.86 |
1.06 |
.96 |
.99 |
| ATP | 1.01 |
.98 |
.69 |
.69 |
.97 |
.87 |
1.09 |
| KLA/ATP | 1.00 |
.97 |
.74 |
.74 |
.81 |
.86 |
1.17 |
|
Cyp2e1 | |
NM_021282 |
cytochrome P450, family 2, subfamily e, polypeptide 1 (Cyp2e1), mRNA [NM_021282] |
KLA | .99 |
1.03 |
1.05 |
1.01 |
.99 |
1.06 |
1.00 |
| ATP | .96 |
.93 |
.98 |
1.05 |
1.01 |
1.03 |
1.10 |
| KLA/ATP | 1.04 |
.99 |
1.02 |
1.00 |
1.05 |
1.04 |
.99 |
|
Cyp3a11 | |
NM_007818 |
cytochrome P450, family 3, subfamily a, polypeptide 11 (Cyp3a11), mRNA [NM_007818] |
KLA | .96 |
.94 |
1.06 |
1.04 |
.96 |
.94 |
.97 |
| ATP | 1.00 |
1.01 |
.94 |
.95 |
.94 |
.92 |
.98 |
| KLA/ATP | .98 |
1.06 |
1.06 |
.98 |
.88 |
.93 |
.91 |
|
Cyp3a13 | |
NM_007819 |
cytochrome P450, family 3, subfamily a, polypeptide 13 (Cyp3a13), mRNA [NM_007819] |
KLA | .99 |
.98 |
.98 |
1.03 |
.97 |
1.01 |
1.07 |
| ATP | 1.00 |
1.01 |
1.01 |
1.04 |
1.01 |
.99 |
1.00 |
| KLA/ATP | 1.06 |
1.01 |
1.00 |
1.08 |
1.09 |
1.01 |
1.09 |
|
Cyp3a16 | |
NM_007820 |
cytochrome P450, family 3, subfamily a, polypeptide 16 (Cyp3a16), mRNA [NM_007820] |
KLA | .95 |
.99 |
.96 |
.96 |
1.00 |
1.03 |
.99 |
| ATP | 1.04 |
1.03 |
.98 |
.97 |
.98 |
1.03 |
1.01 |
| KLA/ATP | .96 |
.91 |
.96 |
.97 |
1.03 |
1.00 |
1.04 |
|
Cyp3a25 | |
NM_019792 |
cytochrome P450, family 3, subfamily a, polypeptide 25 (Cyp3a25), mRNA [NM_019792] |
KLA | 1.00 |
.96 |
1.01 |
1.04 |
.99 |
.99 |
1.01 |
| ATP | 1.01 |
1.02 |
.97 |
1.01 |
1.02 |
.93 |
.95 |
| KLA/ATP | .97 |
1.09 |
1.04 |
1.01 |
.99 |
.97 |
.97 |
|
Cyp3a41a
| |
NM_017396 |
cytochrome P450, family 3, subfamily a, polypeptide 41A (Cyp3a41a), mRNA [NM_017396] |
KLA | 1.02 |
.99 |
.98 |
.95 |
.93 |
.93 |
1.06 |
| ATP | 1.00 |
.96 |
1.02 |
.97 |
.97 |
.95 |
1.02 |
| KLA/ATP | 1.03 |
1.02 |
1.07 |
.97 |
.93 |
.97 |
.97 |
|
Cyp3a44 | |
NM_177380 |
cytochrome P450, family 3, subfamily a, polypeptide 44 (Cyp3a44), mRNA [NM_177380] |
KLA | 1.05 |
1.03 |
1.05 |
1.02 |
1.08 |
1.00 |
1.03 |
| ATP | .97 |
1.00 |
1.03 |
1.07 |
.99 |
.99 |
.99 |
| KLA/ATP | 1.04 |
.99 |
.99 |
1.06 |
1.04 |
1.06 |
1.00 |
|
Ephx1 | |
NM_010145 |
epoxide hydrolase 1, microsomal (Ephx1), mRNA [NM_010145] |
KLA | .90 |
.97 |
.94 |
.80 |
.69 |
.47 |
.19 |
| ATP | 1.10 |
1.20 |
1.02 |
1.41 |
1.02 |
.63 |
.23 |
| KLA/ATP | 1.09 |
1.04 |
.83 |
1.21 |
.78 |
.58 |
.29 |
|
Gsta1 | |
NM_008181 |
glutathione S-transferase, alpha 1 (Ya) (Gsta1), mRNA [NM_008181] |
KLA | .94 |
1.06 |
1.07 |
.99 |
.99 |
1.13 |
1.08 |
| ATP | 1.01 |
1.00 |
1.07 |
1.04 |
1.13 |
1.82 |
3.26 |
| KLA/ATP | 1.04 |
.96 |
.98 |
1.12 |
1.15 |
1.07 |
1.39 |
|
Gsta2 | |
NM_008182 |
glutathione S-transferase, alpha 2 (Yc2) (Gsta2), mRNA [NM_008182] |
KLA | 1.01 |
.97 |
.99 |
.97 |
.98 |
1.02 |
.93 |
| ATP | 1.04 |
1.03 |
.98 |
.93 |
1.05 |
1.54 |
2.11 |
| KLA/ATP | 1.00 |
.97 |
1.05 |
1.01 |
.97 |
1.03 |
1.14 |
|
Gsta3 | |
NM_001077353 |
glutathione S-transferase, alpha 3 (Gsta3), transcript variant 1, mRNA [NM_001077353] |
KLA | .93 |
.95 |
.88 |
.86 |
.60 |
.52 |
.91 |
| ATP | 1.00 |
.95 |
1.30 |
1.00 |
.97 |
2.01 |
4.26 |
| KLA/ATP | .93 |
1.03 |
1.22 |
.97 |
.77 |
.75 |
3.30 |
|
Gsta4 | |
NM_010357 |
glutathione S-transferase, alpha 4 (Gsta4), mRNA [NM_010357] |
KLA | 1.03 |
1.00 |
1.00 |
.99 |
.99 |
.98 |
.96 |
| ATP | .99 |
1.03 |
.98 |
.99 |
.99 |
1.09 |
1.25 |
| KLA/ATP | 1.02 |
1.01 |
1.01 |
.99 |
.96 |
1.00 |
1.04 |
|
Gstk1 | |
AK002661 |
adult male kidney cDNA, RIKEN full-length enriched library, clone:0610025I19 product:GLUTATHIONE S-TRANSFERASE, MITOCHONDRIAL (EC 2.5.1.18) (GST 13-13) (GLUTATHIONE S-TRANSFERASE SUBUNIT 13) (GST CLASS-KAPPA) homolog [Rattus norvegicus], |
KLA | 1.05 |
1.02 |
1.06 |
1.05 |
.91 |
.81 |
.60 |
| ATP | .93 |
.85 |
1.40 |
1.29 |
1.23 |
1.00 |
.72 |
| KLA/ATP | .98 |
1.09 |
1.61 |
1.33 |
1.36 |
.86 |
.62 |
|
Gstm1 | |
NM_010358 |
glutathione S-transferase, mu 1 (Gstm1), mRNA [NM_010358] |
KLA | .94 |
.95 |
1.04 |
.94 |
.85 |
.74 |
.76 |
| ATP | 1.12 |
1.15 |
1.17 |
1.92 |
1.78 |
2.30 |
2.03 |
| KLA/ATP | 1.12 |
1.15 |
1.06 |
1.74 |
1.66 |
2.20 |
3.26 |
|
Gstm2 | |
NM_008183 |
glutathione S-transferase, mu 2 (Gstm2), mRNA [NM_008183] |
KLA | 1.23 |
1.15 |
1.23 |
1.24 |
1.20 |
1.07 |
.96 |
| ATP | 1.11 |
1.06 |
1.37 |
1.96 |
2.12 |
2.41 |
5.20 |
| KLA/ATP | 1.18 |
1.33 |
1.57 |
1.98 |
1.96 |
1.90 |
3.42 |
|
Gstm3 | |
NM_010359 |
glutathione S-transferase, mu 3 (Gstm3), mRNA [NM_010359] |
KLA | .88 |
.88 |
.84 |
.79 |
.78 |
.69 |
.70 |
| ATP | .99 |
1.04 |
1.13 |
1.58 |
1.64 |
1.88 |
1.81 |
| KLA/ATP | .93 |
.94 |
.99 |
1.47 |
1.54 |
1.92 |
2.72 |
|
Gstm4 | |
NM_026764 |
glutathione S-transferase, mu 4 (Gstm4), mRNA [NM_026764] |
KLA | .91 |
.98 |
.95 |
.98 |
1.04 |
.94 |
1.45 |
| ATP | 1.08 |
1.15 |
.86 |
1.13 |
.83 |
.63 |
1.19 |
| KLA/ATP | 1.03 |
1.07 |
.90 |
.92 |
.64 |
.76 |
1.82 |
|
Gstm5 | |
NM_010360 |
glutathione S-transferase, mu 5 (Gstm5), mRNA [NM_010360] |
KLA | 1.00 |
1.11 |
.97 |
.99 |
.88 |
.64 |
.53 |
| ATP | 1.02 |
1.13 |
1.18 |
1.47 |
1.17 |
.86 |
.76 |
| KLA/ATP | 1.16 |
1.13 |
1.09 |
1.38 |
1.01 |
.73 |
.62 |
|
Gstm6 | |
NM_008184 |
glutathione S-transferase, mu 6 (Gstm6), mRNA [NM_008184] |
KLA | 1.00 |
.99 |
.99 |
1.02 |
1.05 |
.98 |
.99 |
| ATP | .96 |
.97 |
.98 |
.99 |
1.10 |
.95 |
.99 |
| KLA/ATP | .98 |
.92 |
1.02 |
1.01 |
1.05 |
.97 |
1.00 |
|
Gstm7 | |
AK002213 |
adult male kidney cDNA, RIKEN full-length enriched library, clone:0610005A07 product:GLUTATHIONE S-TRANSFERASE, MU TYPE 3 (YB3) homolog [Mus musculus], full insert sequence. [AK002213] |
KLA | .99 |
.93 |
.95 |
.98 |
1.04 |
.98 |
.92 |
| ATP | 1.03 |
1.01 |
.98 |
.97 |
.98 |
.98 |
.98 |
| KLA/ATP | .92 |
.92 |
.98 |
.91 |
1.00 |
.92 |
.99 |
|
Gstm7 | |
NM_026672 |
glutathione S-transferase, mu 7 (Gstm7), mRNA [NM_026672] |
KLA | .97 |
1.03 |
.96 |
1.02 |
.91 |
.96 |
.95 |
| ATP | 1.02 |
.99 |
1.00 |
1.00 |
1.00 |
.88 |
.90 |
| KLA/ATP | 1.00 |
1.03 |
.95 |
.96 |
1.01 |
.95 |
.89 |
|
Gsto1 | |
NM_010362 |
glutathione S-transferase omega 1 (Gsto1), mRNA [NM_010362] |
KLA | .84 |
.81 |
.84 |
.76 |
.62 |
.54 |
.61 |
| ATP | 1.09 |
1.04 |
1.23 |
1.78 |
1.95 |
1.75 |
.96 |
| KLA/ATP | .88 |
.87 |
1.05 |
1.30 |
1.31 |
1.18 |
.77 |
|
Gsto2 | |
NM_026619 |
glutathione S-transferase omega 2 (Gsto2), mRNA [NM_026619] |
KLA | 1.03 |
1.07 |
1.03 |
1.00 |
.98 |
1.12 |
1.10 |
| ATP | .94 |
.90 |
1.01 |
2.25 |
1.86 |
1.00 |
1.03 |
| KLA/ATP | .98 |
.96 |
1.02 |
1.87 |
2.11 |
1.15 |
1.21 |
|
Gstp1 | |
NM_013541 |
glutathione S-transferase, pi 1 (Gstp1), mRNA [NM_013541] |
KLA | .99 |
.99 |
.98 |
.92 |
.92 |
.79 |
.85 |
| ATP | 1.06 |
1.10 |
1.06 |
1.27 |
1.13 |
1.62 |
2.31 |
| KLA/ATP | .98 |
1.02 |
1.03 |
1.22 |
1.02 |
1.25 |
2.47 |
|
Gstt1 | |
NM_008185 |
glutathione S-transferase, theta 1 (Gstt1), mRNA [NM_008185] |
KLA | 1.23 |
1.46 |
1.64 |
1.80 |
2.33 |
3.37 |
4.15 |
| ATP | 1.02 |
1.03 |
1.10 |
1.18 |
1.01 |
1.05 |
.99 |
| KLA/ATP | 1.43 |
1.61 |
1.40 |
1.58 |
1.37 |
1.43 |
2.11 |
|
Gstt2 | |
NM_010361 |
glutathione S-transferase, theta 2 (Gstt2), mRNA [NM_010361] |
KLA | 1.05 |
1.08 |
1.02 |
1.08 |
1.33 |
1.48 |
1.33 |
| ATP | .96 |
.98 |
.96 |
1.15 |
1.07 |
.76 |
1.12 |
| KLA/ATP | 1.02 |
1.07 |
1.20 |
1.41 |
1.41 |
1.23 |
2.59 |
|
Gstt3 | |
NM_133994 |
glutathione S-transferase, theta 3 (Gstt3), mRNA [NM_133994] |
KLA | .78 |
.79 |
.76 |
.74 |
.68 |
.65 |
.61 |
| ATP | .96 |
.87 |
.93 |
.82 |
.63 |
.42 |
.74 |
| KLA/ATP | .76 |
.75 |
.89 |
.76 |
.68 |
.74 |
2.44 |
|
Hsd11b1 | |
NM_008288 |
hydroxysteroid 11-beta dehydrogenase 1 (Hsd11b1), transcript variant 1, mRNA [NM_008288] |
KLA | 1.02 |
1.05 |
1.08 |
1.06 |
1.17 |
1.25 |
2.06 |
| ATP | 1.06 |
1.08 |
1.05 |
1.15 |
1.10 |
1.21 |
1.70 |
| KLA/ATP | 1.09 |
1.13 |
1.12 |
1.11 |
1.15 |
1.21 |
1.71 |
|
Mgst1 | |
NM_019946 |
microsomal glutathione S-transferase 1 (Mgst1), mRNA [NM_019946] |
KLA | 1.00 |
1.03 |
1.02 |
1.00 |
1.03 |
1.03 |
1.68 |
| ATP | 1.01 |
1.02 |
1.12 |
1.22 |
1.38 |
2.86 |
2.13 |
| KLA/ATP | 1.01 |
1.06 |
1.06 |
1.28 |
1.38 |
2.77 |
3.05 |
|
Mgst2 | |
NM_174995 |
microsomal glutathione S-transferase 2 (Mgst2), mRNA [NM_174995] |
KLA | 2.87 |
2.54 |
2.80 |
3.26 |
2.70 |
2.43 |
1.43 |
| ATP | 1.04 |
1.05 |
1.48 |
1.33 |
1.13 |
1.39 |
6.05 |
| KLA/ATP | 2.10 |
2.54 |
4.49 |
3.33 |
2.57 |
1.87 |
3.13 |
|
Mgst3 | |
AK008211 |
adult male small intestine cDNA, RIKEN full-length enriched library, clone:2010012L10 product:RIKEN cDNA 2010012L10 gene, full insert sequence. [AK008211] |
KLA | 1.04 |
.98 |
.89 |
.88 |
.69 |
.44 |
.15 |
| ATP | 1.05 |
1.16 |
1.34 |
1.66 |
1.17 |
.70 |
.25 |
| KLA/ATP | .94 |
1.02 |
1.07 |
1.41 |
1.02 |
.72 |
.15 |
|
Mgst3 | |
NM_025569 |
microsomal glutathione S-transferase 3 (Mgst3), mRNA [NM_025569] |
KLA | 1.04 |
1.03 |
.87 |
.83 |
.69 |
.47 |
.17 |
| ATP | 1.00 |
1.13 |
1.18 |
1.47 |
1.16 |
.69 |
.26 |
| KLA/ATP | 1.02 |
.98 |
.92 |
1.29 |
.93 |
.74 |
.17 |
|
Mm.26684 3 | |
94405693 |
Unknown |
KLA | 1.12 |
.99 |
.99 |
1.00 |
.97 |
.98 |
.96 |
| ATP | 1.02 |
1.08 |
1.01 |
.90 |
1.02 |
.97 |
.91 |
| KLA/ATP | 1.03 |
.96 |
.98 |
.91 |
1.05 |
.90 |
.97 |
|
Mm.26940
| |
113680351 |
Unknown |
KLA | .71 |
.71 |
.72 |
.65 |
.63 |
.83 |
.93 |
| ATP | .94 |
.87 |
1.23 |
1.30 |
1.21 |
1.41 |
1.76 |
| KLA/ATP | .70 |
.69 |
.89 |
.88 |
1.21 |
1.51 |
1.45 |
|
Mm.29467 8 | |
124487254 |
Unknown |
KLA | 1.01 |
1.07 |
1.03 |
.98 |
1.02 |
1.09 |
1.02 |
| ATP | 1.02 |
1.00 |
1.02 |
1.08 |
.96 |
1.04 |
.97 |
| KLA/ATP | 1.01 |
1.00 |
1.05 |
1.05 |
1.01 |
1.06 |
1.01 |
|
Mm.30009 5 | |
145699117 |
Unknown |
KLA | .70 |
.74 |
.85 |
.84 |
.90 |
.85 |
.90 |
| ATP | .83 |
.77 |
.93 |
.98 |
1.05 |
1.04 |
.86 |
| KLA/ATP | .72 |
.70 |
.86 |
.97 |
1.13 |
.80 |
.83 |
|
Mm.34137
| |
94405716 |
Unknown |
KLA | 1.11 |
1.12 |
1.10 |
1.07 |
1.08 |
1.13 |
1.36 |
| ATP | 1.09 |
1.14 |
1.01 |
1.25 |
.95 |
.79 |
1.23 |
| KLA/ATP | 1.01 |
1.24 |
.95 |
1.14 |
.83 |
.78 |
1.30 |
|
Mm.38984 8 | |
116268117 |
Unknown |
KLA | .98 |
1.02 |
1.01 |
1.05 |
.97 |
.97 |
.96 |
| ATP | .95 |
1.01 |
1.04 |
1.14 |
.99 |
.91 |
1.01 |
| KLA/ATP | 1.08 |
.92 |
1.02 |
1.00 |
.97 |
.97 |
.99 |
|
Mm.39459 3 | |
116325998 |
Unknown |
KLA | .96 |
1.01 |
.98 |
.95 |
.98 |
.93 |
1.03 |
| ATP | 1.00 |
.98 |
.97 |
1.12 |
1.01 |
1.00 |
1.12 |
| KLA/ATP | 1.02 |
1.00 |
1.00 |
.98 |
1.04 |
1.01 |
1.05 |
|
Mm.42277 8 | |
118130920 |
Unknown |
KLA | 1.00 |
1.01 |
1.08 |
1.04 |
.99 |
.98 |
1.01 |
| ATP | 1.07 |
1.11 |
1.03 |
.98 |
1.08 |
2.66 |
3.31 |
| KLA/ATP | .95 |
1.05 |
1.04 |
.96 |
1.00 |
1.14 |
1.44 |
|
Mm.42607 7 | |
58743309 |
Unknown |
KLA | .98 |
.93 |
1.04 |
1.03 |
.97 |
.98 |
1.16 |
| ATP | 1.02 |
.95 |
1.02 |
1.06 |
.96 |
.95 |
1.04 |
| KLA/ATP | .98 |
.97 |
.98 |
1.01 |
.99 |
1.11 |
.91 |
|
Mm.46685 9 | |
145699102 |
Unknown |
KLA | .65 |
.64 |
.75 |
.87 |
.83 |
.79 |
.82 |
| ATP | .80 |
.77 |
.97 |
.86 |
1.13 |
1.05 |
.85 |
| KLA/ATP | .64 |
.65 |
.85 |
.86 |
1.16 |
.69 |
.72 |
|
Nat1 | |
NM_008673 |
N-acetyltransferase 1 (arylamine N-acetyltransferase) (Nat1), mRNA [NM_008673] |
KLA | .97 |
.98 |
1.00 |
.94 |
1.01 |
.95 |
1.02 |
| ATP | 1.03 |
.96 |
1.01 |
1.04 |
1.03 |
.99 |
1.01 |
| KLA/ATP | 1.03 |
.98 |
.94 |
1.00 |
.99 |
1.05 |
.86 |
|
Nat2 | |
NM_010874 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) (Nat2), mRNA [NM_010874] |
KLA | 3.59 |
3.77 |
3.60 |
2.69 |
2.11 |
2.24 |
1.44 |
| ATP | .96 |
.91 |
.74 |
.42 |
.39 |
1.32 |
1.45 |
| KLA/ATP | 3.43 |
3.33 |
2.84 |
1.60 |
.89 |
2.12 |
2.09 |
|
Nat3 | |
NM_008674 |
N-acetyltransferase 3 (Nat3), mRNA [NM_008674] |
KLA | 1.00 |
1.06 |
1.05 |
1.02 |
1.07 |
1.05 |
1.11 |
| ATP | .98 |
.99 |
1.05 |
1.05 |
1.04 |
1.02 |
1.11 |
| KLA/ATP | 1.03 |
.95 |
.96 |
1.03 |
.96 |
1.04 |
.99 |
|
Ptgs2 | |
NM_011198 |
prostaglandin-endoperoxide synthase 2 (Ptgs2), mRNA [NM_011198] |
KLA | 181.04 |
220.88 |
218.58 |
132.79 |
103.05 |
22.69 |
18.02 |
| ATP | 2.47 |
9.45 |
52.13 |
208.62 |
271.22 |
306.11 |
6.86 |
| KLA/ATP | 233.39 |
387.29 |
617.86 |
###.## |
608.44 |
290.80 |
112.22 |
|
Sult1a1 | |
NM_133670 |
sulfotransferase family 1A, phenol-preferring, member 1 (Sult1a1), mRNA [NM_133670] |
KLA | .66 |
.67 |
.66 |
.63 |
.44 |
.28 |
.09 |
| ATP | .96 |
.88 |
.95 |
.99 |
.73 |
.30 |
.08 |
| KLA/ATP | .66 |
.63 |
.70 |
.71 |
.62 |
.34 |
.10 |
|
Ugt1a1 | |
NM_201645 |
UDP glucuronosyltransferase 1 family, polypeptide A1 (Ugt1a1), mRNA [NM_201645] |
KLA | .95 |
1.07 |
1.00 |
.99 |
.97 |
.98 |
1.02 |
| ATP | 1.08 |
.95 |
1.02 |
1.04 |
1.08 |
1.03 |
1.01 |
| KLA/ATP | 1.02 |
.95 |
.93 |
1.01 |
1.01 |
1.11 |
1.06 |
|
Ugt1a6b | |
NM_201410 |
UDP glucuronosyltransferase 1 family, polypeptide A6B (Ugt1a6b), mRNA [NM_201410] |
KLA | .89 |
.86 |
.93 |
.93 |
.89 |
.86 |
.89 |
| ATP | 1.10 |
1.05 |
1.15 |
1.07 |
1.01 |
.99 |
1.24 |
| KLA/ATP | .90 |
.94 |
1.02 |
.89 |
.87 |
.81 |
.92 |
|
Ugt1a9 | |
NM_201644 |
UDP glucuronosyltransferase 1 family, polypeptide A9 (Ugt1a9), mRNA [NM_201644] |
KLA | 1.07 |
.96 |
.98 |
1.09 |
1.03 |
1.06 |
1.08 |
| ATP | 1.04 |
.94 |
1.01 |
1.07 |
1.05 |
1.02 |
1.06 |
| KLA/ATP | 1.05 |
1.00 |
.94 |
1.01 |
1.03 |
1.04 |
1.00 |
|
Ugt2a1 | |
NM_053184 |
UDP glucuronosyltransferase 2 family, polypeptide A1 (Ugt2a1), mRNA [NM_053184] |
KLA | 1.01 |
1.03 |
.99 |
.99 |
.99 |
1.01 |
1.02 |
| ATP | 1.01 |
.93 |
1.04 |
1.03 |
1.02 |
1.01 |
1.03 |
| KLA/ATP | 1.04 |
1.01 |
1.01 |
1.02 |
1.01 |
1.02 |
1.00 |
|
Ugt2a3 | |
NM_028094 |
UDP glucuronosyltransferase 2 family, polypeptide A3 (Ugt2a3), mRNA [NM_028094] |
KLA | 1.07 |
1.01 |
.97 |
1.05 |
1.01 |
.98 |
.99 |
| ATP | .98 |
.96 |
1.04 |
1.06 |
.95 |
.94 |
1.01 |
| KLA/ATP | 1.02 |
1.00 |
.94 |
1.02 |
1.02 |
1.01 |
1.06 |
|
Ugt2b1 | |
NM_152811 |
UDP glucuronosyltransferase 2 family, polypeptide B1 (Ugt2b1), mRNA [NM_152811] |
KLA | 1.08 |
1.01 |
.95 |
1.08 |
1.00 |
1.04 |
.97 |
| ATP | 1.03 |
1.14 |
1.01 |
1.00 |
1.01 |
1.05 |
1.13 |
| KLA/ATP | 1.05 |
.99 |
1.06 |
.98 |
1.03 |
.96 |
.98 |
|
Ugt2b34 | |
NM_153598 |
UDP glucuronosyltransferase 2 family, polypeptide B34 (Ugt2b34), mRNA [NM_153598] |
KLA | .98 |
1.08 |
.99 |
1.06 |
.97 |
1.05 |
1.03 |
| ATP | 1.06 |
1.04 |
.96 |
1.01 |
1.03 |
1.01 |
.99 |
| KLA/ATP | 1.09 |
.94 |
1.00 |
1.07 |
1.01 |
1.03 |
.97 |
|
Ugt2b35 | |
NM_172881 |
UDP glucuronosyltransferase 2 family, polypeptide B35 (Ugt2b35), mRNA [NM_172881] |
KLA | .99 |
1.02 |
.99 |
1.01 |
1.00 |
.96 |
1.01 |
| ATP | .96 |
1.02 |
1.02 |
.96 |
.93 |
1.00 |
1.02 |
| KLA/ATP | 1.01 |
.99 |
1.04 |
1.00 |
.97 |
.93 |
.97 |
|
Ugt2b36 | |
NM_001029867 |
UDP glucuronosyltransferase 2 family, polypeptide B36 (Ugt2b36), mRNA [NM_001029867] |
KLA | .95 |
.95 |
1.00 |
1.00 |
1.03 |
1.02 |
.92 |
| ATP | 1.02 |
1.07 |
1.03 |
.95 |
1.01 |
.93 |
1.00 |
| KLA/ATP | .99 |
1.05 |
.98 |
1.04 |
1.02 |
.98 |
.99 |
|
Ugt2b37 | |
NM_053215 |
UDP glucuronosyltransferase 2 family, polypeptide B37 (Ugt2b37), mRNA [NM_053215] |
KLA | 1.02 |
1.06 |
1.04 |
1.05 |
1.00 |
1.05 |
1.03 |
| ATP | 1.01 |
1.03 |
1.08 |
1.01 |
1.05 |
1.02 |
1.05 |
| KLA/ATP | 1.01 |
.99 |
1.11 |
1.14 |
1.04 |
1.08 |
1.05 |
|
Ugt2b38 | |
NM_133894 |
UDP glucuronosyltransferase 2 family, polypeptide B38 (Ugt2b38), mRNA [NM_133894] |
KLA | 1.00 |
.96 |
1.04 |
.99 |
1.10 |
.97 |
.99 |
| ATP | 1.02 |
1.04 |
1.03 |
.94 |
.96 |
.93 |
.99 |
| KLA/ATP | .98 |
.97 |
1.00 |
.97 |
.98 |
1.04 |
1.02 |
|
Ugt2b5 | |
NM_009467 |
UDP glucuronosyltransferase 2 family, polypeptide B5 (Ugt2b5), mRNA [NM_009467] |
KLA | 1.01 |
.99 |
1.09 |
.96 |
.97 |
.99 |
1.01 |
| ATP | 1.03 |
1.02 |
1.02 |
1.01 |
.97 |
.90 |
.94 |
| KLA/ATP | .99 |
.99 |
.98 |
1.05 |
1.01 |
.93 |
.95 |
|